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Abstract
Background:  Cross-clamp fibrillation is a well established method of performing coronary
grafting, but its clinical effect on the myocardium is unknown. We sought to measure these effects
clinically using the Khuri Intramyocardial pH monitor.
Methods: 50 episodes of cross-clamping were recorded in 16 patients who underwent CABG
with crossclamp-fibrillation. An Intramyocardial pH probe measured the level of acidosis in the
anterior and posterior myocardium in real-time. The pH at the start and end of each period of
cross-clamping was recorded.
Results: It became very apparent that the pH of some patients recovered quickly while others
entirely failed to recover. Thus the patients were split into 2 groups according to whether the pH
recovered to above 6.8 after the first crossclamp-release (N = 8 in each group). Initial pH was 7.133
(range 6.974–7.239). After the first period of crossclamping the pH dropped to 6.381 (range 6.034–
6.684). The pH in recoverers prior to the second XC application was 6.990(range 6.808–7.222)
compared to only 6.455 (range 6.200–6.737) in patient's whose myocardium did not recover (P <
0.0005). This finding was repeated after the second XC release (mean pH 7.005 vs 6.537) and the
third (mean pH 6.736 vs 6.376). However prior to separation from bypass the pH was close to the
initial pH in both groups (7.062 vs 7.038).
Conclusion: Crossclamp fibrillation does not result in reliable reperfusion of the myocardium
between periods of crossclamping.
Background
Cross Clamp fibrillationn is a well established technique
for performing Coronary Bypass Grafting and it is rou-
tinely used by 15% of surgeons in the UK [1-3] Propo-
nents of this technique report that this method subjects
the heart to only short periods of ischaemia, with full
reperfusion after every distal anastomosis. In addition the
possibility that ischaemic preconditioning occurs as sub-
sequent grafts are performed is proposed to further protect
the myocardium [4-6]. It is commonly thought that
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ischaemic periods of up to 10–15 minutes are easily toler-
ated by the myocardium and clinical practise would sug-
gest that cross-clamp fibrillation has identical outcomes
to coronary bypass surgery using cardioplegia. However
no study has yet been performed that has demonstrated
adequate reperfusion between periods of cross clamp
fibrillation and the phenomenon of ischaemic precondi-
tioning has not yet been clinically demonstrated during
cardiac surgery.
The Khuri Myocardial pH monitor has been recently
developed that can for the first time provide real-time
clinical analysis of the myocardial pH during cardiopul-
monary bypass [7-10]. It has been well validated during
cardiopulmonary bypass with cardioplegia in over 500
clinical cases and periods of low intramyocardial pH have
been correlated with increased myocardial damage[11].
We sought to investigate the effect of cross-clamp fibrilla-
tion on the pH of the myocardium with the primary
hypothesis that we may be able to define a 'safe-ischaemic
time' for cross-clamping, and a secondary hypothesis that
we may be able to measure ischaemic preconditioning in
clinical practise for the first time.
Methods
16 patients undergoing elective coronary bypass grafting
using cross-clamp fibrillation had a Khuri intramyocar-
dial pH monitor placed intra-operatively. The monitor
consists of two probes. The first (anterior) probe is placed
prior to cardiopulmonary bypass into the left ventricle,
lateral to the LAD, directed obliquely into the anterior
ventricular septum. The second probe is placed lateral to
the posterior descending artery, again in an oblique fash-
ion so that the tip rests in the posterior portion of the ven-
tricular septum. Continuous pH monitoring is then
performed with pH measurements recorded every 10 sec-
onds. Cardiopulmonary bypass was performed at 37
degrees centigrade, but the pH probe also contains a tem-
perature probe and provides a pH value corrected to nor-
mothermia.
Operative technique was not modified in any way for this
study. The PDA or RCA was first grafted with the cross
clamp applied for the distal anastomosis and released as
the proximal anastomosis is formed. Lateral wall grafts
were then performed, with the LAD being the last graft to
be placed. The maximal pH recovery was determined as
the pH just before the subsequent cross clamp placement.
The posterior probe was removed prior to separation from
bypass but the anterior probe remained in place until sep-
aration from bypass and a constant final pH reading was
achieved.
Statistical analysis
The pH recordings were analysed and the pH recordings
prior to, 5 minutes into and after crossclamping were
recorded. The average values of the anterior and the pos-
terior probe recordings were taken. In addition the maxi-
mum pH recovery after crossclamp removal was
documented (which was recorded only by the anterior
probe). 2 groups were retrospectively defined according to
whether the pH recovered to above 6.8. The cut-off point
of 6.8 was determined purely by an observational assess-
ment and the conclusion that patients whose pH did not
recover to above this level seemed to be different to those
that did. The 2 groups were created simply to highlight
this observational difference. The pH values were com-
pared between these groups using the unpaired Student t-
test, after normality was established using the Kol-
mogorov-Smirnov test.
Results
20 patients were entered into the study but 3 patients had
malpositioning of the pH probe and puncture of the left
ventricle causing misreading, and in a 4th  patient the
probe was opened but not used. The remaining 16
patients had 50 periods of crossclamping to fashion 47
distal anastomoses. The demographics of these patients
are shown in table 1. When the traces were analysed, it
became clear that the pH recovered well on release of the
crossclamp for some patients, but in other patients there
was a complete failure to recover (See figures 1 and 2). We
therefore split the data into two groups as well as analys-
ing the traces as a whole. The full results of the analysis are
shown in table 2.
The initial pH was 7.133 (range 6.974–7.239) for the
group as a whole. On cross-clamping the pH reduced,
with mean pH after the first cross-clamp removal being
6.381 (SD 0.165 and range 6.034–6.684). The recovery
after cross clamp removal was highly inconsistent. The
mean pH at the end of the first period of cross clamp
release was 6.723 (SD 0.324), but in patients we termed
as non-recoverers the mean pH rose to only 6.455 (SD
0.067) compared to recoverers whose pH rose to 6.990
(SD 0.561). These findings were repeated for subsequent
applications of the cross-clamp. However at the end of the
period of pH measurement (Once off bypass) there was
no significant difference in myocardial pH between these
two groups [7.062 (SD 0.0945) in recoverers and 7.038
(SD 0.258) in the non-recoverers (p = 0.810)].
We further subanalysed the rate of descent of the pH in
the 8 patients who did have acceptable recovery of the pH
on cross clamp removal. We found that the rate of descent
after the first cross clamp was 0.355 in 5 minutes, the rate
of descent after the second cross clamp was 0.186 in 5
minutes and the rate of descent after the third cross clampJournal of Cardiothoracic Surgery 2006, 1:45 http://www.cardiothoracicsurgery.org/content/1/1/45
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was 0.0152 in 5 minutes. This was a significant reduction
in the rate of descent in pH as the number of periods of
cross-clamping increased (p = 0.009). The clinical out-
comes for the 16 patients are shown in table 3.
Discussion
To our knowledge this is the first study to investigate the
level of ischaemia found in the myocardium during coro-
nary arterial bypass grafting using the technique of cross-
clamp fibrillation. We have documented for the steady
reduction in pH during this technique, which reaches pH
levels as low as 6.03, and on average the pH dropped to
6.38 prior to first cross clamp removal.
We have also documented for the first time 8 patients
whose intramyocardial pH did not recover once the cross
clamp was removed. We hypothesise that the reason for
this lack of recovery is that despite removal of the cross-
clamp, blood did not perfuse the native coronary arteries
(or the graft after second cross clamp removal). The rea-
sons for this lack of perfusion require further research but
possibilities would include the much lower aortic root
pressure than the physiological situation (or the pressure
that cardioplegia is given in patients undergoing cardi-
opelgic techniques) and changes in the resistance of heav-
ily diseased vessels that may now be twisted or
compressed.
One further interesting preliminary finding is that in
those patients who do undergo ischaemia and then recov-
ery, the rate of descent of the pH reduced significantly on
subsequent cross clamp applications. To our knowledge
this is the first demonstration in the clinical situation that
ischaemic preconditioning has been shown. This clinical
demonstration confirms a large number of animal studies
performed up to 20 years ago that clearly show the exist-
ence of ischaemic preconditioning [12-15].
Our study has many weaknesses due to its preliminary
nature. The splitting of our patients into 2 groups was
entirely retrospective in nature and was done in order to
understand further the results we were seeing for the first
time. However while we felt that the two groups behaved
very differently, there may in fact be a spectrum of patients
rather than two distinct groups. This requires further
patients to undergo intramyocardial pH monitoring dur-
ing cross-clamp fibrillation. Secondly our initial report of
ischaemic preconditioning is based on only 8 patients and
this requires many more patients to establish that this is a
physiological phenomenon in everyday clinical practise.
It has been clearly and repeatedly demonstrated in well-
conducted prospective randomized trials that the tech-
nique of cross clamp fibrillation is equivalent to both crys-
talloid and blood cardioplegia in terms of clinical
outcome and biochemical markers of myocardial damage
[16-22]. In 1998 Liu et al[17] compared the results of
1,345 patients who had cross-clamp fibrillation with 578
patients who had coronary arterial bypass grafts with cold
crystalloid cardioplegia at one institution during the same
time period. The groups had identical mortality, stroke
rates, ICU stay, haemofiltration rates and resternotomy
rates. Alhan et al[20] compared 128 patients having
CABG with cold crystalloid cardioplegia with 271 patients
having CABG with crossclamp fibrillation, and found no
differences in clinical outcomes, including mortality,
Table 1: Demographics of the patient cohort
Total (N = 16) Recoverers (N = 8) Non Recoverers (N = 8)
Age 67 (SD 9) 66 (SD 2) 67 SD(4)
Male 15 7 8
Diabetes (on insulin) 1 0 1
Ex/current smokers 12 6 6
BMI 28 (SD 3) 29 (SD 1) 27 (SD 1)
EF 63 (SD 14) 61 (SD 7) 65 (SD 4)
Prev MI 7 5 2
LMS disease 9 5 4
Triple vessel disease 14 6 8
Euroscore 2.6 (SD 1.7) 2.6 (SD 0.7) 2.5 (SD 0.5)
INTRAOPERATIVE DATA
CABG × 2 2 2 0
CABG × 3 13 6 7
CABG × 4 1 0 1
BIMA usage 4 1 3
Mean single XC time 9 (SD 2) range 4–15 mins 8.6 (SD 0.3) range 5–12 mins 9.5 (SD 0.5) range 4–15 mins
XC time 29 (SD 7) 28 (SD 3) 30 (SD 2)
Bypass time 68 (SD 16) 69 (SD 7) 67 (SD 4)Journal of Cardiothoracic Surgery 2006, 1:45 http://www.cardiothoracicsurgery.org/content/1/1/45
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IABP use, inotropic requirements and myocardial infarc-
tion. Gerola et al[22] performed a prospective rand-
omized trial of 60 patients randomized to either
aspartate-glutamate enriched warm blood cardioplegia or
cross clamp fibrillation. Again there were no differences in
mortality, cardiac index, or myocardial infarction rates.
Finally, in a prospective randomized trial, Musumeci et
al[18] randomized 43 patients to cross clamp fibrillation
and 48 to cold blood cardioplegia. Levels of CK. MB, S-
100B, Troponin I and T, LV function, ECG changes and
number of cerebral micro-emboli were either similar
between the two groups or superior in the crossclamp
fibrillation group.
Thus clinically and biochemically cross clamp fibrillation
is indistinguishable from cardioplegic techniques. In con-
trast Khuri et al have performed over 500 measurements
of intamyocardial pH during cardiac surgery using cardio-
plegia. He has correlated a pH of below 6.87 at the end of
bypass with an increase in inotrope requirement[7] and a
pH of below 6.34 during crossclamping with an increase
in long term mortality[8,9]. In addition he has found that
the level of apoptosis in samples of myocardium exposed
to a pH of 6.34 was three times higher than tissue at nor-
mal pH[11].
We have established that the pH of the myocardium rou-
tinely falls to very low levels during cross clamp fibrilla-
tion. However repeated studies have shown equivalence
between cross clamp fibrillation and cardioplegic tech-
niques. Thus it is possible that Khuri's findings of poorer
short and long term outcomes with lower pH levels in
patients having surgery using cardioplegia would not
extrapolate to patients having periods of profound myo-
cardial acidosis during cross clamp fibrillation.
Our preliminary study cannot answer whether ischaemic
preconditioning accounts for the heart's ability to sustain
this profound ischaemia during cross clamp fibrillation
and indeed our finding of several patients who had sus-
pH recordings from application of crossclamp, though release, until application of second cross clamp, allowing maximal time  for recovery Figure 1
pH recordings from application of crossclamp, though release, until application of second cross clamp, allowing maximal time 
for recovery. The traces that recovered are represented by the light lines, and the traces that failed to recover are repre-
sented by the heavy black lines.Journal of Cardiothoracic Surgery 2006, 1:45 http://www.cardiothoracicsurgery.org/content/1/1/45
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An example of a patient with successful reperfusion (Top light line) and a patient with unsuccessful reperfusion (lower heavy  line) Figure 2
An example of a patient with successful reperfusion (Top light line) and a patient with unsuccessful reperfusion (lower heavy 
line). The arrows represent application and release of the crossclamp. Of note the patient that did not have recovery received 
a RIMA graft as the second anastomosis.
Table 2: Results of pH analysis with Khuri Intramyocardial pH probe
Total Ph Recoverers non recoverers p value
Initial pH 7.133 (SD 0.0635)
range 6.974–7.239
7.132 (SD 0.0121) 7.134 (SD 0.0305) 0.958
pH after 1st XC 6.381 (SD 0.165)
range 6.034–6.684
6.445 (SD 0.126) 6.317 (SD 0.183) 0.124
pH Recovery after 1st XC 6.723 (SD 0.324)
range 6.200–7.222
6.990 (SD 0.561)
range 6.808–7.222
6.455 (SD 0.067)
range 6.2000–6.737.
<0.0005
pH after 2nd XC 6.495 (SD 0.192)
range 6.118 – 6.820
6.610 (SD 0.131) 6.381 (SD 0.180) 0.012
Ph Recovery after 2nd XC 6.769 (SD 0.303)
range 6.210 – 7.159
7.005 (SD 0.1193) 6.537 (SD 0.240) <0.0005
pH after 3rd XC 6.530 (SD 0.267)
range 6.19 to 6.89
6.736 (SD 0.159) 6.376 (SD 0.224) 0.006
pH recovery after 3rd XC 6.919 (SD 0.304)
range 6.23 to 7.28
7.081 (SD 0.0838) 6.798 (SD 0.356) 0.084
Final pH 7.050 (SD 0.188)
range 6.55–7.33.
7.062 (SD 0.0945) 7.038 (SD 0.258) 0.810
pH drop for each period of cross clamping
Drop in 5 mins 1st XC 0.355 (SD 0.0690) 0.320 (SD 0.165)
Drop in 5 mins 2nd XC 0.186 (SD 0.175) 0.0742 (SD 0.0708)
Drop in 5 mins 3rd XC 0.152 (SD 0.0696) 0.103 (SD 0.119)
P value 0.009Journal of Cardiothoracic Surgery 2006, 1:45 http://www.cardiothoracicsurgery.org/content/1/1/45
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tained ischaemia suggest that the mechanisms by which
the myocardium is protected from apoptosis remain
unknown.
We suggest that further studies of patients undergoing
crossclamp fibrillation are performed in order to further
elucidate the factors that allow adequate reperfusion and
also to investigate the clinical phenomenon of ischaemic
preconditioning. Furthermore we were unable to deter-
mine a 'safe-period' for crossclamp application due to the
intermittent nature of reperfusion. Once further studies
are performed to elucidate the conditions for reliable
reperfusion, a 'safe-ischaemic time' may become possible
to determine.
Conclusion
Crossclamp fibrillation does not result in reliable reper-
fusion of the myocardium between periods of crossclamp-
ing.
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